首页> 美国卫生研究院文献>BMJ Case Reports >Novel treatment (new drug/intervention; established drug/procedure in new situation): H pylori-induced thrombocytopenia in a Caucasian female: a case report
【2h】

Novel treatment (new drug/intervention; established drug/procedure in new situation): H pylori-induced thrombocytopenia in a Caucasian female: a case report

机译:新疗法(新药/干预;新情况下已确立的药物/程序):白人女性中幽门螺杆菌诱发的血小板减少症:一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We present a rare, but increasingly recognised, cause of thrombocytopenia in a 69-year-old Caucasian female. Complete haematological investigation, including blood films and autoantibody screen, did not reveal a cause for her thrombocytopenia. Omission of potentially offending medication did not improve the low platelet count. She had no features of systemic infection or inflammatory disease on history and examination. In light of persistent thrombocytopenia, Helicobacter pylori stool antigen was tested, and found to be positive. Platelet count improved after eradication therapy for H pylori. This prevented the need for steroid and immunoglobulin treatment in this patient.
机译:我们介绍了一位69岁的白人女性中血小板减少症的罕见原因,但人们越来越认识到它。完整的血液学检查,包括血膜检查和自身抗体检查,未发现其血小板减少的原因。省略可能引起不适的药物并不能改善血小板计数低的情况。根据病史和检查,她没有全身感染或炎症性疾病的特征。鉴于持续性血小板减少症,对幽门螺杆菌粪便抗原进行了检测,结果为阳性。根除幽门螺杆菌后,血小板计数提高。这避免了对该患者进行类固醇和免疫球蛋白治疗的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号